UBS Group’s BioNTech BNTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$27.5M Sell
258,288
-235,643
-48% -$25.1M ﹤0.01% 1614
2025
Q1
$45M Sell
493,931
-35,122
-7% -$3.2M 0.01% 1240
2024
Q4
$60.3M Buy
529,053
+406,072
+330% +$46.3M 0.01% 1004
2024
Q3
$14.6M Sell
122,981
-42,563
-26% -$5.06M ﹤0.01% 1459
2024
Q2
$13.3M Buy
165,544
+73,416
+80% +$5.9M ﹤0.01% 1455
2024
Q1
$8.5M Sell
92,128
-21,650
-19% -$2M ﹤0.01% 1719
2023
Q4
$12M Sell
113,778
-12,264
-10% -$1.29M ﹤0.01% 1354
2023
Q3
$13.7M Buy
126,042
+23,073
+22% +$2.51M ﹤0.01% 1231
2023
Q2
$11.1M Buy
102,969
+15,345
+18% +$1.66M ﹤0.01% 1373
2023
Q1
$10.9M Sell
87,624
-39,068
-31% -$4.87M ﹤0.01% 1318
2022
Q4
$19M Sell
126,692
-14,557
-10% -$2.19M 0.01% 1027
2022
Q3
$19.1M Sell
141,249
-35,224
-20% -$4.75M 0.01% 946
2022
Q2
$26.3M Buy
176,473
+5,439
+3% +$811K 0.01% 844
2022
Q1
$29.2M Sell
171,034
-163,839
-49% -$27.9M 0.01% 859
2021
Q4
$86.3M Sell
334,873
-14,758
-4% -$3.8M 0.02% 472
2021
Q3
$95.4M Buy
349,631
+43,057
+14% +$11.8M 0.03% 423
2021
Q2
$68.6M Buy
306,574
+22,845
+8% +$5.11M 0.02% 514
2021
Q1
$31M Buy
283,729
+230,057
+429% +$25.1M 0.01% 837
2020
Q4
$4.38M Sell
53,672
-59,879
-53% -$4.88M ﹤0.01% 1961
2020
Q3
$7.86M Buy
113,551
+60,713
+115% +$4.2M ﹤0.01% 1425
2020
Q2
$3.53M Buy
52,838
+47,948
+981% +$3.2M ﹤0.01% 1844
2020
Q1
$286K Buy
4,890
+3,840
+366% +$225K ﹤0.01% 3631
2019
Q4
$36K Buy
+1,050
New +$36K ﹤0.01% 5482